Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Biofouling ; 30(6): 719-27, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24856309

RESUMO

Dermatophytes are fungi responsible for a disease known as dermatophytosis. Biofilms are sessile microbial communities surrounded by extracellular polymeric substances (EPS) with increased resistance to antimicrobial agents and host defenses. This paper describes, for the first time, the characteristics of Trichophyton rubrum and T. mentagrophytes biofilms. Biofilm formation was analyzed by light microscopy, scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM) as well as by staining with crystal violet and safranin. Metabolic activity was determined using the XTT reduction assay. Both species were able to form mature biofilms in 72 h. T. rubrum biofilm produced more biomass and EPS and was denser than T. mentagrophytes biofilm. The SEM results demonstrated a coordinated network of hyphae in all directions, embedded within EPS in some areas. Research and characterization of biofilms formed by dermatophytes may contribute to the search of new drugs for the treatment of these mycoses and might inform future revisions with respect to the dose and duration of treatment of currently available antifungals.


Assuntos
Arthrodermataceae/fisiologia , Biofilmes/crescimento & desenvolvimento , Hifas/ultraestrutura , Trichophyton/fisiologia , Análise de Variância , Arthrodermataceae/metabolismo , Violeta Genciana , Microscopia Confocal , Microscopia Eletrônica de Varredura , Fenazinas , Especificidade da Espécie , Sais de Tetrazólio , Trichophyton/metabolismo
2.
Eur J Clin Microbiol Infect Dis ; 32(11): 1377-91, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24141976

RESUMO

Cryptococcosis is an important systemic mycosis and the third most prevalent disease in human immunodeficiency virus (HIV)-positive individuals. The incidence of cryptococcosis is high among the 25 million people with HIV/acquired immunodeficiency syndrome (AIDS), with recent estimates indicating that there are one million cases of cryptococcal meningitis globally per year in AIDS patients. In Cryptococcus neoformans, resistance to azoles may be associated with alterations in the target enzyme encoded by the gene ERG11, lanosterol 14α-demethylase. These alterations are obtained through mutations, or by overexpressing the gene encoding. In addition, C. gattii and C. neoformans present a heteroresistance phenotype, which may be related to increased virulence. Other species beyond C. neoformans and C. gattii, such as C. laurentii, have been diagnosed mainly in patients with immunosuppression. Infections of C. albidus have been isolated in cats and marine mammals. Recent evidence suggests that the majority of infections produced by this pathogen are associated with biofilm growth, which is also related with increased resistance to antifungal agents. Therefore, there is a great need to search for alternative antifungal agents for these fungi. The search for new molecules is currently occurring from nanoparticle drugs of plant peptide origin. This article presents a brief review of the literature regarding the epidemiology of cryptococcosis, as well as fungal resistance and new alternatives for treatment.


Assuntos
Antifúngicos/uso terapêutico , Criptococose/tratamento farmacológico , Criptococose/epidemiologia , Cryptococcus/efeitos dos fármacos , Farmacorresistência Fúngica , Animais , Antifúngicos/farmacologia , Gatos , Criptococose/microbiologia , Criptococose/veterinária , Cryptococcus/isolamento & purificação , Descoberta de Drogas/métodos , Descoberta de Drogas/tendências , Humanos
3.
J Clin Microbiol ; 51(4): 1250-2, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23345296

RESUMO

CLSI method M27-A3 is not available for use with dimorphic fungi, such as those of the Paracoccidioides genus. In this study, we developed a microdilution method and added the alamarBlue reagent to test the responses of Paracoccidioides brasiliensis and Paracoccidioides lutzii against amphotericin B and itraconazole antifungals. The test proved to be sensitive, practical, and inexpensive and can be used to monitor the activity of low-growth microorganisms and their response to various drugs.


Assuntos
Antifúngicos/farmacologia , Oxazinas/metabolismo , Paracoccidioides/efeitos dos fármacos , Coloração e Rotulagem/métodos , Xantenos/metabolismo , Anfotericina B/farmacologia , Humanos , Itraconazol/farmacologia , Testes de Sensibilidade Microbiana/métodos , Paracoccidioides/crescimento & desenvolvimento , Paracoccidioides/metabolismo
4.
J Med Microbiol ; 62(Pt 1): 10-24, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23180477

RESUMO

The incidence of fungal infections has increased significantly, so contributing to morbidity and mortality. This is caused by an increase in antimicrobial resistance and the restricted number of antifungal drugs, which retain many side effects. Candida species are major human fungal pathogens that cause both mucosal and deep tissue infections. Recent evidence suggests that the majority of infections produced by this pathogen are associated with biofilm growth. Biofilms are biological communities with a high degree of organization, in which micro-organisms form structured, coordinated and functional communities. These biological communities are embedded in a self-created extracellular matrix. Biofilm production is also associated with a high level of antimicrobial resistance of the associated organisms. The ability of Candida species to form drug-resistant biofilms is an important factor in their contribution to human disease. The study of plants as an alternative to other forms of drug discovery has attracted great attention because, according to the World Health Organization, these would be the best sources for obtaining a wide variety of drugs and could benefit a large population. Furthermore, silver nanoparticles, antibodies and photodynamic inactivation have also been used with good results. This article presents a brief review of the literature regarding the epidemiology of Candida species, as well as their pathogenicity and ability to form biofilms, the antifungal activity of natural products and other therapeutic options.


Assuntos
Antifúngicos/uso terapêutico , Biofilmes , Produtos Biológicos/uso terapêutico , Candida/fisiologia , Candidíase/tratamento farmacológico , Candidíase/epidemiologia , Antifúngicos/classificação , Biofilmes/efeitos dos fármacos , Candida/classificação , Candida/patogenicidade , Humanos
5.
Biofouling ; 28(7): 711-8, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22784100

RESUMO

The pathogenic fungus, Histoplasma capsulatum, causes the respiratory and systemic disease 'histoplasmosis'. This disease is primarily acquired via inhalation of aerosolized microconidia or hyphal fragments of H. capsulatum. Evolution of this respiratory disease depends on the ability of H. capsulatum yeasts to survive and replicate within alveolar macrophages. It is known that adhesion to host cells is the first step in colonization and biofilm formation. Some microorganisms become attached to biological and non-biological surfaces due to the formation of biofilms. Based on the importance of biofilms and their persistence on host tissues and cell surfaces, the present study was designed to investigate biofilm formation by H. capsulatum yeasts, as well as their ability to adhere to pneumocyte cells. H. capsulatum biofilm assays were performed in vitro using two different clinical strains of the fungus and biofilms were characterized using scanning electron microscopy. The biofilms were measured using a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium-hydroxide (XTT) reduction assay. The results showed that both the H. capsulatum strains tested were very efficient at adhering to host cells and forming biofilm. Therefore, this is a possible survival strategy adopted by this fungus.


Assuntos
Células Epiteliais Alveolares/microbiologia , Biofilmes , Histoplasma/patogenicidade , Células Epiteliais Alveolares/metabolismo , Adesão Celular , Linhagem Celular , Histoplasma/metabolismo , Histoplasma/fisiologia , Histoplasmose/microbiologia , Interações Hospedeiro-Patógeno , Humanos , Microscopia Eletrônica de Varredura , Sais de Tetrazólio/metabolismo
6.
J Toxicol Environ Health B Crit Rev ; 12(8): 553-71, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20183534

RESUMO

Fibrin sealant, a widely available tissue adhesive, has been used since 1940 in a variety of clinical applications. Commercially available fibrin sealant products are synthesized from bovine thrombin and human fibrinogen, which may transmit infectious diseases, and recipients may also develop antibodies against bovine thrombin. Bearing these disadvantages in mind, a new fibrin sealant was developed in 1989 by a group of researchers from the Center for the Study of Venoms and Venomous Animals, in Sao Paulo State, Brazil. The main purpose was to produce an adhesive fibrin without using human blood, to avoid transmitting infectious diseases. The components of this novel sealant were extracted from large animals and a serine proteinase extracted from Crotalus durissus terrificus snake venom. The applicability of this sealant was tested in animals and humans with beneficial results. The new fibrin sealant can be a useful tool clinically due to its flexibility and diversity of applications. This sealant is a biological and biodegradable product that (1) does not produce adverse reactions, (1) contains no human blood, (3) has a good adhesive capacity, (4) gives no transmission of infectious diseases, and (5) may be used as an adjuvant in conventional suture procedures. The effectiveness of this new fibrin sealant is reviewed and its development and employment are described.


Assuntos
Venenos de Crotalídeos/uso terapêutico , Crotalus , Adesivo Tecidual de Fibrina/uso terapêutico , Hemostáticos/uso terapêutico , Adesivos Teciduais/uso terapêutico , Animais , Venenos de Crotalídeos/efeitos adversos , Venenos de Crotalídeos/isolamento & purificação , Adesivo Tecidual de Fibrina/efeitos adversos , Adesivo Tecidual de Fibrina/isolamento & purificação , Hemostáticos/efeitos adversos , Hemostáticos/isolamento & purificação , Humanos , Procedimentos Cirúrgicos Operatórios , Adesivos Teciduais/efeitos adversos , Adesivos Teciduais/isolamento & purificação
7.
Lett Appl Microbiol ; 46(5): 542-7, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18363650

RESUMO

AIMS: The aim of this study was to identify and determine the diversity, occurrence and distribution of fungi in water used at a haemodialysis centre. METHODS AND RESULTS: Samples in the hydraulic circuit for the distribution of the water, dialysate samples and samples of sterilization solution from dialysers were collected over a 3-month period, and 500 ml of each sample was filtered through membranes. All together 116 isolates of fungi were recovered from 89% of all water samples collected inside the haemodialysis unit, with prevalence of moulds in tap water samples and of yeasts in dialysate samples. Fusarium spp. was the most abundant genus found, whereas Candida parapsilosis was the predominant yeast species. CONCLUSIONS: This study demonstrated that various fungi were present in the water system. These data suggest the inclusion of the detection and quantification of fungi in the water of haemodialysis. SIGNIFICANCE AND IMPACT OF THE STUDY: The recovery of fungi from aqueous haemodialysis environments implies a potential risk for haemodialysis patients and indicates the need for continuous maintenance and monitoring. Further studies on fungi in haemodialysis water systems are required to investigate the organism ability to persist, their role in biofilm formation and their clinical significance.


Assuntos
Soluções para Diálise , Fungos/isolamento & purificação , Diálise Renal , Microbiologia da Água , Brasil , Contagem de Colônia Microbiana , Testes de Sensibilidade a Antimicrobianos por Disco-Difusão , Contaminação de Equipamentos , Fluconazol/farmacologia , Fungos/classificação , Fungos/efeitos dos fármacos , Unidades Hospitalares de Hemodiálise , Humanos , Filtros Microporos/microbiologia
8.
Rev. ciênc. farm. básica apl ; 29(1): 97-106, 2008. ilus, tab
Artigo em Inglês | LILACS | ID: lil-528566

RESUMO

P. brasiliensis parasitizes various human tissues and proteinases exported by this fungus may allow it to metabolize and invade host tissues. The influence of the culture medium on the production of proteinases by P. brasiliensis isolates was studied and the export of these enzymes was followed as a function of culture time. The fungus was grown in neopeptone, BSA, elastin orcollagen medium. The culture medium was assayed for azocollytic, elastinolytic and caseinolytic activity. Proteolytic activity was also analysed by electrophoresis of the culture medium on gelatin and casein substrate gels. P. brasiliensis expressed relatively high levels of azocoll, elastin and casein degrading activity in all types of medium, except in neopeptone medium. Generally, expression of azocollytic activity peaked during the third week of culture and caseinolytic activity during the fourth week of culture. Azocollytic activity was highest at pH 4.0 and caseinolytic activity at pH 8.0. Elastinolytic activity was also highest at pH 8.0. This activity, as well as the others, may provide the fungus with a source of carbon and nitrogen and may alsobe responsible for the invasion of host tissues, such as pulmonary elastic fiber, by P. brasiliensis.


Assuntos
Humanos , Paracoccidioidomicose , Paracoccidioides/isolamento & purificação , Peptídeo Hidrolases/análise
9.
Antonie Van Leeuwenhoek ; 92(1): 129-35, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17120081

RESUMO

Paracoccidioidomycosis is caused by Paracoccidioides brasiliensis, which although not formally considered an intracellular pathogen, can be internalized by epithelial cells in vitro and in vivo. The mechanisms used by P. brasiliensis to adhere to and invade non-professional phagocytes have not been identified. The signal-transduction networks, involving protein tyrosine kinase (PTK) and protein phosphatase activities, can modulate crucial events during fungal infections. In this study, the involvement of PTK has been investigated in P. brasiliensis adherence and invasion in mammalian epithelial cells. A significant inhibition of the fungal invasion occurred after the pre-treatment of the epithelial cells with genistein, a specific tyrosine kinase inhibitor, indicating that the tyrosine kinase pathway is involved in P. brasiliensis internalization. In contrast, when the fungus was treated, a slight (not significant) inhibition of PTK was observed, suggesting that PTK might not be the fungus' transduction signal pathway during the invasion process of epithelial cells. An intense PTK immunofluorescence labeling was observed in the periphery of the P. brasiliensis infected cells, little PTK labeling was found in both uninfected cells and yeast cells, at later infection times (8 and 24 h). Moreover, when the epithelial cells were treated with genistein and infected with P. brasiliensis, no labeling was observed, suggesting the importance of the PTK in the infectious process. These results suggest that PTK pathway participates in the transduction signal during the initial events of the adhesion and invasion processes of P. brasiliensis to mammalian epithelial cells.


Assuntos
Aderência Bacteriana/efeitos dos fármacos , Endocitose/efeitos dos fármacos , Células Epiteliais/efeitos dos fármacos , Genisteína/farmacologia , Paracoccidioides/efeitos dos fármacos , Linhagem Celular Tumoral , Inibidores Enzimáticos/farmacologia , Células Epiteliais/metabolismo , Células Epiteliais/microbiologia , Humanos , Microscopia Confocal , Paracoccidioides/crescimento & desenvolvimento , Proteínas Tirosina Quinases/antagonistas & inibidores , Proteínas Tirosina Quinases/metabolismo , Transdução de Sinais/efeitos dos fármacos
10.
Rev. ciênc. farm. básica apl ; 28(1): 25-34, 2007. tab, ilus
Artigo em Inglês | LILACS | ID: lil-485198

RESUMO

Antifungal activity of natural products has been tested by adapting methods designed for synthetic drugs. Inthis study, two methods for the determination of antifungal activity of natural products, agar diffusionand broth microdilution, the CLSI reference methods for synthetic drugs, are compared and discussed. Themicrodilution method was more sensitive. The minimal inhibitory concentrations (MIC) of crude extracts,fractions and pure substances from different species of the plant families Piperaceae, Rubiaceae, Clusiaceae, Fabaceae and Lauraceae, from the Biota project, were determined. Antifungal activities against Candida albicans, C.krusei, C.parapsilosis and Cryptococcus neoformans were produced by several samples


Atividade antifúngica de produtos naturais foi determinada após algumas adaptações de métodos preconizados para fármacos sintéticos. Neste estudo foram comparados e discutidos os métodos para determinação de atividade antifúngica de produtos naturais por duas metodologias, difusão em ágar e microdiluição em caldo, segundo método preconizado pelo CLSI para fármacos sintéticos. A concentração mínima inibitória foi determinada de extratos brutos, frações e de substâncias puras de diferentes espécies de plantas das famílias Piperaceae, Rubiaceae, Clusiaceae, Fabaceae and Lauraceae do projeto Biota. Vários apresentaram atividade antifúngica para as levedurasCandida albicans, C.krusei, C.parapsilosis and Cryptococcus neoformans.


Assuntos
Antígenos de Fungos , Candida albicans , Cryptococcus , Produtos Biológicos/antagonistas & inibidores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA